FBXO30 and posterior cortical atrophy: Although we found FBXO30 to be significantly downregulated in PCa versus nonmalignant PCa tissue samples in the cohort from TCGA, others have reported FBXO30 as upregulated in PCa and for example in nasopharyngeal cancer [30].